By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Anchor Therapeutics 

67 Rogers Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-715-1999 Fax: 617-715-7906



Company News
Anchor Therapeutics Enters Into Collaborative Research Agreement With Kyowa Hakko Kirin for its Pepducin Technology 7/31/2012 9:51:28 AM
Anchor Therapeutics Achieves Milestone in GPCR Collaboration 1/10/2011 11:45:58 AM
Anchor Therapeutics Announces Collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc., Potential $480 Million in Milestones 9/9/2010 6:33:31 AM
Anchor Therapeutics Nabs $10M for New Class of Peptide Drugs Against Hard Targets 8/20/2010 6:58:03 AM
Anchor Therapeutics Adds Global Experts to Board of Directors and Scientific Advisory Board 7/21/2010 12:41:38 PM
Ascent Therapeutics Changes Name to Anchor Therapeutics 3/30/2010 8:51:30 AM
Ascent Therapeutics Achieves Preclinical in vivo Proof-of-Principle with Novel Pepducin(TM) GPCR Modulator Platform and Strengthens Senior Management Team 9/11/2009 9:52:08 AM
Ascent Therapeutics Appoints Industry Leaders to Senior Management Team 6/3/2009 8:54:11 AM
Massachusetts Biotechnology Council, Inc. Release: 19 Biotech Companies Selected to Present at 10th Annual MassBio Investors Forum 12/2/2008 12:29:28 PM
Ascent Therapeutics Debuts with the Appointment of CEO; $19 Million Series A 11/18/2008 8:28:28 AM